Switzerland Views

Pages

FDA Approves Velphoro

On November 27, the FDA approved Velphoro (PA21; sucroferric oxyhydroxide) for the treatment of hyperphosphataemia in chronic kidney disease patients on dialysis. The product, owned by Vifor...

Read article ›

Pages